Carregant...
Outcome after Radiotherapy for Langerhans Cell Histiocytosis Is Dependent on Site of Involvement
PURPOSE: Langerhans cell histiocytosis (LCH) is a rare malignant disease characterized by histiocytic proliferation. We intended to characterize the efficacy and safety of radiation therapy (RT) in a contemporary cohort and to explore if there are sites at higher risk for local recurrence. MATERIALS...
Guardat en:
| Publicat a: | Int J Radiat Oncol Biol Phys |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5806138/ https://ncbi.nlm.nih.gov/pubmed/29413280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2017.10.053 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|